Cargando…
Targeted Nanoparticles for Imaging Incipient Pancreatic Ductal Adenocarcinoma
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) carries an extremely poor prognosis, typically presenting with metastasis at the time of diagnosis and exhibiting profound resistance to existing therapies. The development of molecular markers and imaging probes for incipient PDAC would enable ear...
Autores principales: | Kelly, Kimberly A, Bardeesy, Nabeel, Anbazhagan, Rajesh, Gurumurthy, Sushma, Berger, Justin, Alencar, Herlen, DePinho, Ronald A, Mahmood, Umar, Weissleder, Ralph |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292750/ https://www.ncbi.nlm.nih.gov/pubmed/18416599 http://dx.doi.org/10.1371/journal.pmed.0050085 |
Ejemplares similares
-
Genetics and biology of pancreatic ductal adenocarcinoma
por: Ying, Haoqiang, et al.
Publicado: (2016) -
Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
por: Chouari, Tarak, et al.
Publicado: (2023) -
Incipient Tuberculosis
Publicado: (1913) -
Incipient Decay
Publicado: (1899) -
Incipient Insanity
Publicado: (1923)